Thermo Fisher Scientific (NYSE:TMO) launched its TacroType Pharmacogenetic Test for transplant patients. The test is designed to support more personalized tacrolimus dosing based on a patient's ...
Thermo Fisher Scientific Inc. (TMO) 47th Annual Raymond James Institutional Investor Conference March 3, 2026 9:15 AM ESTCompany ParticipantsMarc Casper ...
Thermo Fisher Scientific, the world leader in serving science, today announced the launch of Thermo Scientific(TM) Brilliance(TM) Candida 2 Agar and Spectra(TM) Candida Agar**, ne ...
Thermo Fisher Scientific Introduces New Fluid Ease Pro ClipTip to Support Comfortable and Reproducible Pipetting Across Laboratory Workflows. Overview:Thermo Fisher Scientific introduces the Fluid ...
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best strong buy healthcare stocks to invest in. Thermo Fisher ...
Thermo Fisher Scientific Inc. (NYSE:TMO) is among the best stocks in each sector in 2026. On February 9, Matt Larew, an analyst at William Blair, reiterated a Buy rating on Thermo Fisher Scientific ...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors ...
Thermo Fisher Scientific is launching a new test it says can help doctors avoid the “trial-and-error” approach typically used to dose patients with a common antirejection drug after organ transplant ...
This insight explores the $1.1B primary cell market, highlighting how leaders like Lonza, Thermo Fisher, Cloud-Clone, ...
AZoM on MSN
Industrial Applications of FTIR Spectroscopy
Advances in FTIR instrumentation support quantitative industrial analysis.
Ms. Lacks’s family accused Novartis of profiting from her cells, which were taken from her without her consent in 1951, when ...
The Henrietta Lacks estate has secured a settlement with Novartis over the unauthorized use of her cancer cells, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results